Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 7
2003 5
2004 4
2005 5
2006 8
2007 6
2008 6
2009 10
2010 5
2011 3
2012 7
2013 8
2014 7
2015 6
2016 4
2017 9
2018 1
2019 4
2020 11
2021 13
2022 7
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Results by year

Filters applied: . Clear all
Page 1
Effects of DPP-4 inhibitors, GLP-1 receptor agonists, SGLT-2 inhibitors and sulphonylureas on mortality, cardiovascular and renal outcomes in type 2 diabetes: A network meta-analyses-driven approach.
Brønden A, Christensen MB, Glintborg D, Snorgaard O, Kofoed-Enevoldsen A, Madsen GK, Toft K, Kristensen JK, Højlund K, Hansen TK, Søndergaard E, Hansen KB. Brønden A, et al. Diabet Med. 2023 Aug;40(8):e15157. doi: 10.1111/dme.15157. Epub 2023 Jun 12. Diabet Med. 2023. PMID: 37249579 Review.
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
von Herrath M, Bain SC, Bode B, Clausen JO, Coppieters K, Gaysina L, Gumprecht J, Hansen TK, Mathieu C, Morales C, Mosenzon O, Segel S, Tsoukas G, Pieber TR; Anti-IL-21–liraglutide Study Group investigators and contributors. von Herrath M, et al. Lancet Diabetes Endocrinol. 2021 Apr;9(4):212-224. doi: 10.1016/S2213-8587(21)00019-X. Epub 2021 Mar 1. Lancet Diabetes Endocrinol. 2021. PMID: 33662334 Clinical Trial.
Assessment of ghrelin.
Espelund U, Hansen TK, Ørskov H, Frystyk J. Espelund U, et al. APMIS Suppl. 2003;(109):140-5. APMIS Suppl. 2003. PMID: 12874966 Review.
Normal Physiology of Growth Hormone in Adults.
Olarescu NC, Gunawardane K, Hansen TK, Møller N, Jørgensen JOL. Olarescu NC, et al. 2019 Oct 16. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. 2019 Oct 16. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. PMID: 25905284 Free Books & Documents. Review.
The Effect of Insulin Degludec Versus Insulin Glargine U100 on Glucose Metrics Recorded During Continuous Glucose Monitoring in People With Type 1 Diabetes and Recurrent Nocturnal Severe Hypoglycemia.
Brøsen JMB, Agesen RM, Alibegovic AC, Andersen HU, Beck-Nielsen H, Gustenhoff P, Hansen TK, Hedetoft C, Jensen TJ, Juhl CB, Stolberg CR, Lerche SS, Nørgaard K, Parving HH, Tarnow L, Thorsteinsson B, Pedersen-Bjergaard U. Brøsen JMB, et al. J Diabetes Sci Technol. 2023 Sep 6:19322968231197423. doi: 10.1177/19322968231197423. Online ahead of print. J Diabetes Sci Technol. 2023. PMID: 37671755
Hypoglycemia event prediction from CGM using ensemble learning.
Fleischer J, Hansen TK, Cichosz SL. Fleischer J, et al. Front Clin Diabetes Healthc. 2022 Dec 9;3:1066744. doi: 10.3389/fcdhc.2022.1066744. eCollection 2022. Front Clin Diabetes Healthc. 2022. PMID: 36992787 Free PMC article.
Effect of dipeptidyl peptidase-4 inhibitors on complement activation.
Hoffmann-Petersen IT, Holt CB, Jensen L, Hage C, Mellbin LG, Thiel S, Hansen TK, Østergaard JA. Hoffmann-Petersen IT, et al. Among authors: hansen tk. Diabetes Metab Res Rev. 2021 Mar;37(3):e3385. doi: 10.1002/dmrr.3385. Epub 2020 Aug 18. Diabetes Metab Res Rev. 2021. PMID: 32662092 Clinical Trial.
132 results